Royalty Pharma annual operating margin
2018
2019
2020
2021
2022
2023
2024
2025
Royalty Pharma Operating Margin Growth & History (RPRX)
Royalty Pharma's operating margin was 65.58% for fiscal 2025.
View full Royalty Pharma company overviewRoyalty Pharma annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 65.58% | +8.48 pp |
| 2024 | 2024-12-31 | 57.10% | −6.28 pp |
| 2023 | 2023-12-31 | 63.37% | +49.65 pp |
| 2022 | 2022-12-31 | 13.73% | −48.77 pp |
| 2021 | 2021-12-31 | 62.49% | −12.68 pp |
| 2020 | 2020-12-31 | 75.17% | −69.42 pp |
| 2019 | 2019-12-31 | 144.59% | +68.57 pp |
| 2018 | 2018-12-31 | 76.02% | — |
Royalty Pharma quarterly operating margin
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 19.75% | −16.51 pp |
| Q1 2026 | 2026-03-31 | 89.29% | −4.72 pp |
| Q4 2025 | 2025-12-31 | 62.44% | +1.54 pp |
| Q3 2025 | 2025-09-30 | 70.11% | −60.07 pp |
| Q2 2025 | 2025-06-30 | 36.26% | −13.93 pp |
| Q1 2025 | 2025-03-31 | 94.01% | +106.99 pp |
| Q4 2024 | 2024-12-31 | 60.90% | −41.93 pp |
| Q3 2024 | 2024-09-30 | 130.17% | +101.94 pp |
| Q2 2024 | 2024-06-30 | 50.19% | +3.95 pp |
| Q1 2024 | 2024-03-31 | −12.99% | −83.02 pp |
| Q4 2023 | 2023-12-31 | 102.82% | +188.14 pp |
| Q3 2023 | 2023-09-30 | 28.24% | −5.28 pp |
| Q2 2023 | 2023-06-30 | 46.24% | −24.25 pp |
| Q1 2023 | 2023-03-31 | 70.03% | +30.94 pp |
| Q4 2022 | 2022-12-31 | −85.31% | −111.96 pp |
| Q3 2022 | 2022-09-30 | 33.52% | −18.22 pp |
| Q2 2022 | 2022-06-30 | 70.49% | −63.74 pp |
| Q1 2022 | 2022-03-31 | 39.09% | −0.92 pp |
| Q4 2021 | 2021-12-31 | 26.65% | −68.18 pp |
| Q3 2021 | 2021-09-30 | 51.74% | −28.38 pp |
| Q2 2021 | 2021-06-30 | 134.23% | +62.07 pp |
| Q1 2021 | 2021-03-31 | 40.02% | −74.68 pp |
| Q3 2020 | 2020-09-30 | 94.83% | +23.18 pp |
| Q2 2020 · Jun 30 | 2020-06-30 | 80.12% | — |
| Q1 2020 | 2020-03-31 | 72.16% | — |
| Q3 2019 | 2019-09-30 | 114.69% | — |
| Q2 2019 | 2019-06-30 | 71.65% | — |
Royalty Pharma operating margin trends
Over the last five reported fiscal years, Royalty Pharma's operating margin decreased from 75.17% to 65.58%, a change of −9.60 percentage points. The latest reported quarter, Q2 2026, shows 19.75%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Royalty Pharma filings at SEC.gov ↗